News | May 09, 2011

Pioneer of Catheter-Based Aortic Valve Procedures Traces Progress

May 9, 2011 — John Webb, M.D., FSCAI, has traveled the globe teaching fellow physicians how to repair or replace faulty heart valves using minimally invasive techniques. In a keynote Founders’ Lecture delivered at the Society for Cardiovascular Angiography and Interventions (SCAI) 2011 Scientific Sessions last week, he recount the challenges that arose in developing valve therapies that avoid open-chest surgery. Instead, interventional cardiologists use slender tubes, or catheters, that are threaded into the heart through blood vessels.

“When we started, we thought it was very possible that a transcatheter valve procedure could be developed and could be reproducible, but with no experience, nobody really knew for sure,” said Webb, the McCleod Professor of Heart Valve Intervention at the University of British Columbia in Vancouver.

In his Founders’ Lecture, Webb focused primarily on catheter procedures used to implant new aortic valves, the valve that controls the flow of blood from the heart to the rest of the body. He also addressed the development of transcatheter implantation of pulmonary valves (between the heart and lungs) and mitral valves (between the upper and lower chambers on the left side of the heart). In addition, Webb presented advances in catheter techniques for implanting replacement valves inside artificial valves that have failed after open-chest surgery.

The first catheter procedures to treat constricted aortic valves were being performed just as Webb was beginning his training in interventional cardiology. He became interested in how to improve the technique by doing more than just stretching the calcified aortic valve with a balloon. But the idea of an implantable valve was dismissed by skeptics as too far-fetched.

Refining the technique took many years, said Webb, who has since performed or mentored more than a thousand catheter-based aortic valve replacements in 20 countries.

“With time, as each new problem was identified, we were able to take a careful look at it and analyze it and come up with a way of managing these patients so that these complications would be less likely,” he said. “It was really a story of incremental improvements in the technique and patient selection and the device.”

It was not until about 2006 that Webb became convinced that implantation of an aortic valve with a catheter would become a common procedure. Though practical obstacles still exist, he is confident they can be overcome. He continues to welcome cardiovascular teams to the University of British Columbia for intensive training in the procedure.

For more information: www.scai.org

Related Content

Appropriate Use Criteria Published for Valvular Heart Disease Imaging Tests
News | Clinical Decision Support| October 16, 2017
The American College of Cardiology (ACC), along with several partnering societies, recently released appropriate use...
Low Mortality and Stroke Risks Displayed for Minimally Invasive Aortic Valve Replacements
News | Heart Valve Technology| October 11, 2017
An analysis of more than 1,000 minimally invasive aortic valve replacements and more than 400 additional associated...
Medtronic Announces Post-Market Study for CoreValve Evolut Pro System
News | Heart Valve Technology| October 02, 2017
Medtronic plc recently announced a new post-market clinical study to evaluate its CoreValve Evolut Pro valve in...
Montreal Heart Institute Performs First Robotic Mitral Valve Surgery
News | Robotic Systems| September 22, 2017
The Montreal Heart Institute (MHI) announced the acquisition of the da Vinci Xi, a new-generation surgical robot, and...
Edwards Inspiris Resilia Valve Receives FDA Approval
News | Heart Valve Technology| September 21, 2017
Edwards Lifesciences Corp. recently received U.S. Food and Drug Administration (FDA) approval for its Inspiris Resilia...
Sentinel Cerebral Protection System Significantly Reduces Stroke and Mortality in TAVR
News | Embolic Protection Devices| September 18, 2017
September 18, 2017 – Claret Medical announced publication of a new study in the...
TCT 2017 late-breaking trials and studies that will be presented on the latest cardiology technology clinical trials.
Feature | September 11, 2017
September 11, 2017 — From numerous high-quality submissions, Transcatheter Cardiovascular Therapeutics (TCT) has sele
Protembis Announces Successful First-in-Human Use of  ProtEmbo Cerebral Protection System in European Trial
News | Embolic Protection Devices| September 07, 2017
Protembis GmbH announced the first clinical applications of its ProtEmbo Cerebral Protection System to complement a...
Minneapolis Heart Institute Foundation Enrolls First Patient in TRILUMINATE Tricuspid Repair Trial
News | Heart Valve Technology| September 05, 2017
Minneapolis Heart Institute Foundation announced it has enrolled the first-in-the-world patient in a clinical study to...
World's First Successful 52-mm Transcatheter Tricuspid Valve Implantation Completed in Italy
News | Heart Valve Technology| August 31, 2017
NaviGate Cardiac Structures Inc. (NCSI) announced that its Gate catheter-guided tricuspid atrioventricular valved stent...
Overlay Init